Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring drug action in the cellular context using protein-fragment complementation assays.

Helen Yu1, Mary West, Brigitte H Keon

  • 1Odyssey Thera, San Ramon, CA 94583, USA.

Assay and Drug Development Technologies
|April 20, 2004
PubMed
Summary

Protein-fragment complementation assays (PCAs) enable drug discovery by monitoring protein interactions in live cells. This novel method visualizes cellular signaling pathways and identifies potent inhibitors in real time.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a long-acting relaxin for the treatment of pulmonary hypertension.

British journal of pharmacology·2026
Same author

Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study.

British journal of haematology·2026
Same author

Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR.

Journal of clinical immunology·2026
Same author

Opinion: Why paediatric rheumatologists need to understand inborn errors of immunity.

Frontiers in pediatrics·2026
Same author

Enhancing children's health literacy: a scoping review of resources for 'Curriculum for Wales' health and well-being design, implementation, and assessment.

Health promotion international·2025
Same author

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis.

Journal of medicinal chemistry·2025

Area of Science:

  • Cellular biology
  • Molecular pharmacology
  • Biochemistry

Background:

  • Cellular signal transduction involves dynamic multiprotein complexes interacting with various cellular components.
  • Current drug discovery platforms do not adequately address the native cellular environment of drug targets.
  • Understanding protein-protein interactions within their native context is crucial for effective drug development.

Purpose of the Study:

  • To introduce and validate protein-fragment complementation assays (PCAs) as a novel drug discovery platform.
  • To demonstrate the utility of PCAs in assessing drug and drug targets within their native cellular environment.
  • To visualize and monitor protein complexes and signaling pathway activity in live cells.

Main Methods:

  • Utilized protein-fragment complementation assays (PCAs) based on yellow fluorescent protein.

Related Experiment Videos

  • Expressed full-length mammalian genes linked to reporter gene fragments.
  • Detected protein-protein complex formation via refolding of reporter fragments and quantifiable signal generation.
  • Monitored functional nuclear factor-kappaB (NF-κB) complexes (p50/p65), p65 subunit, and IκBα in live cells.

    • Main Results:

    • Successfully visualized and monitored nuclear factor-kappaB (NF-κB) complexes and related proteins in live cells using PCA.
    • PCA assays showed responses to known agonists and antagonists, mirroring endogenous protein activity.
    • A proof-of-concept high-throughput screen identified potent inhibitors of the NF-κB pathway.

    Conclusions:

    • Protein-fragment complementation assays (PCAs) provide a novel approach for drug discovery.
    • PCAs enable real-time monitoring of dynamic signaling pathways in living cells.
    • This method validates the utility of assessing drug targets within their native cellular context.